Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.
about
Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantationAutologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomasAutologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomasComparison of two methods for carboplatin dosing in children with retinoblastoma.EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model.Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy.All-trans retinoic acid synergizes with topotecan to suppress AML cells via promoting RARα-mediated DNA damageToxicity of the topoisomerase I inhibitors.Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remissionUse of high-dose chemotherapy in front-line therapy of childhood malignant glioma.A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-upManagement and outcome of stage 3 neuroblastoma.The role of 131I-MIBG in high-risk neuroblastoma treatment.Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.Desmoplastic Small Round Cell Tumor: Pathology, Genetics, and Potential Therapeutic Strategies.Desmoplastic small round cell tumor 20 years after its discovery.A pilot trial of tandem autologous peripheral blood progenitor cell transplantation following high-dose thiotepa and carboplatin in children with poor-risk central nervous system tumors.KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia.Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas.Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system.Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7).
P2860
Q24186451-AA0ADF79-4D8F-40B4-9699-C51FF3366B82Q24200521-22B31105-C09A-48DA-811F-75559FA3CCAAQ24234049-88D914C4-82FF-4A2E-910B-33A2F358EDD0Q34065022-C1695816-C332-4E31-964D-325657FACFE1Q34206278-633CA1C1-03E3-4C22-9FD4-F1A23CAC6338Q35102499-7A19DA54-6CF8-4F25-BADA-B5623903EDC4Q35884399-F34ED3F3-11CF-40B3-B066-F7AD7A95B7E1Q36040744-094A2763-3999-44C9-B3C0-68AFB2521826Q36212437-4B86CCC3-002B-47F2-ADB2-E9D79119A018Q36499230-674AFE33-3AF3-446C-85B6-2DEF9C7BC2C5Q36970948-45908EBB-3D6F-4438-99F8-4EEA74168B85Q37056086-DADE5E83-4034-4FFB-AD2B-42CF0A18E654Q37591069-CA9E773A-F79A-4E92-B534-5F524B0A9681Q38608663-3377F574-C121-479F-816B-6E2AF2A5A86BQ38952891-50D72D11-2804-4AA0-A1B3-59A46F4151B3Q39025917-E51A8275-AC41-4356-A920-FA186EE1A8ACQ40518066-0CFE1007-E66B-4F0F-B8A4-BA27BC0CCF1BQ41985731-41E87A03-D0D4-4D0F-A153-C03201583EFAQ44598660-BF9042E7-1C9D-4579-BE41-EDB44F852D8CQ45911250-9AD679CF-FA64-42CD-9CF9-B1DEF25ACB6BQ46884985-E6E28966-ACBD-4328-956A-76866384C690Q48372855-A6F2DA50-7D43-47AE-852E-6B764893A0C9
P2860
Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Topotecan combined with myeloa ...... in children and young adults.
@en
Topotecan combined with myeloa ...... in children and young adults.
@nl
type
label
Topotecan combined with myeloa ...... in children and young adults.
@en
Topotecan combined with myeloa ...... in children and young adults.
@nl
prefLabel
Topotecan combined with myeloa ...... in children and young adults.
@en
Topotecan combined with myeloa ...... in children and young adults.
@nl
P2093
P2860
P356
P1476
Topotecan combined with myeloa ...... in children and young adults.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1703213
P407
P50
P577
2001-09-01T00:00:00Z
P5875
P6179
1022830793